Hsa-mir-210 kit for detecting pregnancy-hypertension syndrome and detecting method thereof
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- SECOND MILITARY MEDICAL UNIV OF THE PEOPLES LIBERATION ARMY
- Publication Date
- 2010-02-10
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
Technical field
[0001] The invention relates to the technical field of medical biology detection, and is a kit for detecting the occurrence and development of pregnancy-induced hypertension syndrome by changing the content of hsa-mir-210 in plasma or serum, and a detection method thereof. Background technique
[0002] Pregnancy-induced hypertension syndrome (pregnancy-induced hypertension) is a unique disease of pregnancy caused by multiple system disorders, which mostly occurs after 20 weeks of pregnancy. The clinical manifestations are high blood pressure, proteinuria, edema. In severe cases, headache, dizziness, blurred vision and other conscious symptoms may occur. If not treated in time, it may cause systemic convulsions or even coma, as well as functional disorders of the kidneys, liver and brain. And blood coagulation disorders are currently one of the main factors of pregnancy, maternal, fetal, and infant deaths. Among them, eclampsia is still the primary cause of materna...